Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs morphine placebo-controlled crossover study on neurocognitive function in healthy adults
NL-OMON50676Active, not recruiting
- Sponsor
- Trevena, Inc.
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of oliceridine and morphine in acute pain (5 arms), sponsored by Trevena, Inc. Primary endpoint: Saccadic eye movement peak velocity. Started Feb 2022; status: active, not recruiting.
02
Drugs
oliceridinemorphine
03
Conditions
acute pain
Beyond the preview
Go deeper on NL-OMON50676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50676.